SOCS2 and hepatocellular carcinoma: In this study, we found that METTL14 may inhibit the progression of hepatocellular carcinoma (HCC) by up‐regulating the expression levels of cysteine sulfinic acid decarboxylase, glutamic‐oxaloacetic transaminase 2, and suppressor of cytokine signaling 2.